resveratrol has been researched along with Cardiomegaly in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (17.50) | 29.6817 |
| 2010's | 27 (67.50) | 24.3611 |
| 2020's | 6 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; He, T; Zhang, J; Zhang, Z | 1 |
| Jia, WW; Lin, S; Lin, Y; Ren, S; Shen, L; Xiao, D; Xiao, W; Yan, PM; Zhang, YY | 1 |
| Chen, J; Ma, E; Peng, L; Ren, DN; Wo, D; Wu, C; Yan, H; Zhu, W | 1 |
| Guan, P; Ji, ES; Luo, LF; Sun, ZM; Wang, N; Zhao, YS; Zhou, J | 1 |
| Akhondzadeh, F; Astani, A; Najjari, R; Ranjbar, AM; Rezvani, ME; Safari, F; Samadi, M; Zare, F | 1 |
| Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ | 1 |
| El-Kadi, AOS; Shoieb, SM | 1 |
| Chen, S; Deng, W; Li, J; Liao, H; Ren, J; Tang, Q; Xu, L; Yang, Z; Zhang, N | 1 |
| Fang, WJ; He, Y; Liu, SK; Peng, XD; Wang, CJ; Zhou, YL | 1 |
| Chen, L; Li, Z; Shi, D; Sun, R; Sun, Y; Xiong, K; Xue, L; Zhang, Y; Zhu, B | 1 |
| Bi, HL; Chen, C; Li, HH; Lin, QY; Wang, QS; Wang, S; Xie, X; Yan, X; Zhang, YL; Zou, LX | 1 |
| Fan, XF; Gong, YS; Han, LP; Li, X; Liu, ZH; Wang, X; Zhang, Y | 1 |
| Beker, D; Chakrabarti, S; Davidge, ST; Dolinsky, VW; Dyck, JR; Levasseur, J; Lopaschuk, GD; Morton, JS; Nagendran, J; Oka, T; Pereira, TJ; Zordoky, BN | 1 |
| Anderson, HD; Behbahani, J; Fandrich, R; Kardami, E; Louis, XL; Movahed, A; Netticadan, T; Thandapilly, SJ; Yu, L; Zhang, S | 1 |
| Al-Arifi, MN; Ansari, MA; El Gendy, MA; Korashy, HM; Maayah, ZH | 1 |
| Doser, TA; Ge, J; Hu, N; Mi, SL; Ren, J; Sun, A; Zhang, Y | 1 |
| Tan, Y; Yao, F; Zhang, N; Zhang, Q | 1 |
| Bu, P; Chen, T; Li, J; Li, N; Liu, H; Liu, J; Wang, S; Zeng, M; Zhang, Y | 1 |
| Bi, C; Cai, B; Chen, H; Feng, D; Li, X; Liang, J; Liu, Y; Lu, Y; Ma, W; Wang, Y; Yang, F; Yin, K; Zhao, L | 1 |
| Bagul, PK; Banerjee, SK; Deepthi, N; Sultana, R | 1 |
| Beauloye, C; Bertrand, L; Daskalopoulos, EP; Dufeys, C; Horman, S | 1 |
| Chen, Y; Fan, Y; Fang, K; Gao, Y; Huang, T; Li, G; Liu, L; Liu, Y; Lv, Y; Tu, Y; Wan, L; Yan, D; Zhang, S | 1 |
| Dorri Mashhadi, F; Hafizi, Z; Jamhiri, M; Safari, F; Zare Mehrjardi, F; Zavvar Reza, J | 1 |
| Jin, L; Li, B; Lian, J; Lin, Y; Liu, J; Wang, J; Xiao, W; Zhang, X; Zhou, L; Zhu, J | 1 |
| Acosta, C; Akinwumi, BC; Anderson, HD; Davies, NM; Lee, DI; Majeed, M; Nagabhushanam, K; Netticadan, T; Raj, P; Thomas, SM; Yu, L | 1 |
| Baksh, S; Chan, AY; Dolinsky, VW; Dyck, JR; Light, PE; Soltys, CL; Viollet, B | 1 |
| Chan, AY; Des Rosiers, C; Dolinsky, VW; Dyck, JR; Light, PE; Robillard Frayne, I | 1 |
| Anderson, HD; Behbahani, J; Juric, D; Kopilas, MA; Louis, XL; Netticadan, T; Thandapilly, SJ; Wojciechowski, P; Yu, L | 1 |
| Wu, JM | 1 |
| Juric, D; Louis, XL; Netticadan, T; Taylor, C; Thandapilly, SJ; Wojciechowski, P; Yu, L | 1 |
| Biala, A; Finckenberg, P; Louhelainen, M; Martonen, E; Merasto, S; Mervaala, E; Muller, DN; Shi, J; Siltanen, A; Tauriainen, E | 1 |
| Davis, FB; Davis, PJ; Lin, HY | 1 |
| Giralt, M; Iglesias, R; Planavila, A; Villarroya, F | 1 |
| Gupta, MP; Pillai, VB; Sundaresan, NR | 1 |
| Hori, YS; Horio, Y; Hosoda, R; Kuno, A; Miura, T; Shimamoto, K; Tanno, M | 1 |
| Hao, DL; Huang, Y; Hui, RT; Li, HL; Liang, CC; Lin, M; Liu, DP; Liu, G; Liu, YQ; Wang, AB; Wei, C; Williams, GM; Zhang, CN | 1 |
| Cui, W; Han, C; Jia, X; Li, N; Liu, C; Liu, Z; Mao, W; Song, Y; Wang, W; Zhang, W; Zhang, X | 1 |
| Liu, ZP; Liu, ZQ; Song, Y; Zhang, XP | 1 |
| Izumi, T; Shioi, T; Yoshida, Y | 1 |
| Chen, M; Gupta, M; Gupta, MP; Pillai, JB; Pillai, VB; Rajamohan, SB; Samant, S | 1 |
2 review(s) available for resveratrol and Cardiomegaly
| Article | Year |
|---|---|
AMPK in cardiac fibrosis and repair: Actions beyond metabolic regulation.
Topics: Aging; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Berberine; Cardiomegaly; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Humans; Metformin; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Resveratrol; Ribonucleotides; Signal Transduction; Stilbenes; Thiazolidinediones; Wound Healing | 2016 |
Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.
Topics: Animals; Cardiomegaly; Cell Survival; Coronary Vessels; Enzyme Activators; Gene Expression; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2011 |
38 other study(ies) available for resveratrol and Cardiomegaly
| Article | Year |
|---|---|
Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Fibrosis; Hemodynamics; Hypertrophy, Left Ventricular; Male; Muscle Cells; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Smad3 Protein; Transforming Growth Factor beta1; Ventricular Function | 2021 |
Mechanistic analysis of resveratrol in cardiac hypertrophy by network pharmacology and animal experiments.
Topics: Animal Experimentation; Animals; Cardiomegaly; Network Pharmacology; Rats; Rats, Sprague-Dawley; Resveratrol | 2022 |
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; NF-kappa B; Rats; Resveratrol; Signal Transduction | 2023 |
Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Cardiomegaly; Gene Expression Regulation; Hypoxia; Male; Oxidative Stress; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Gene Expression; Inflammation; Interleukin-6; Myocytes, Cardiac; Rats; Resveratrol; RNA, Messenger; Sirtuin 1; Transcription, Genetic | 2020 |
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins | 2020 |
Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites.
Topics: Angiotensin II; Antioxidants; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Cell Line; Cytochrome P-450 CYP1B1; Humans; Hydroxyeicosatetraenoic Acids; Myosin Heavy Chains; Protective Agents; Resveratrol; Vasoconstrictor Agents | 2020 |
Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
Topics: Animals; Blotting, Western; Caffeic Acids; Cardiomegaly; Cell Line; Disease Models, Animal; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Phenylephrine; Phenylethyl Alcohol; Polymerase Chain Reaction; Rats; Resveratrol; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2017 |
Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.
Topics: Acetylation; Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Cell Line; Diabetic Cardiomyopathies; Male; Mitochondria; Organelle Biogenesis; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Uncoupling Protein 2; Ventricular Function, Left | 2018 |
Senescence as a novel mechanism involved in β-adrenergic receptor mediated cardiac hypertrophy.
Topics: Animals; Cardiomegaly; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor Proteins; GATA4 Transcription Factor; Gene Expression Regulation; Isoproterenol; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Resveratrol; Stilbenes | 2017 |
Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
Topics: Animals; Biomarkers; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Echocardiography; Heart Function Tests; Male; Mice; Models, Molecular; Myocytes, Cardiac; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Resveratrol; TOR Serine-Threonine Kinases | 2019 |
SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition.
Topics: Animals; Cardiomegaly; Cell Line; Cell Nucleus; Collagen; Down-Regulation; Endothelium; Fibrosis; Isoproterenol; Male; Mesoderm; Mice, Inbred C57BL; Models, Biological; Myocardium; Phosphorylation; Protein Transport; Resveratrol; Sirtuin 1; Smad Proteins; Transforming Growth Factor beta | 2019 |
Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.
Topics: Animals; Blood Pressure; Cardiomegaly; Cells, Cultured; Humans; Hypertension; Mice; Rats; Resveratrol; Stilbenes | 2013 |
Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Cardiovascular System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hemodynamics; Hydralazine; Hypertension; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2013 |
Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway.
Topics: Animals; Cardiomegaly; Cell Survival; Cells, Cultured; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzymes; Gene Expression Regulation; Imidazoles; Indoles; Male; Myocytes, Cardiac; Pyridines; Pyrroles; Rats; Rats, Wistar; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Stilbenes; Sunitinib | 2014 |
Mitochondrial aldehyde dehydrogenase 2 accentuates aging-induced cardiac remodeling and contractile dysfunction: role of AMPK, Sirt1, and mitochondrial function.
Topics: Aging; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; AMP-Activated Protein Kinases; Animals; Apoptosis; Atrial Remodeling; Benzamides; Benzodioxoles; Calcium; Cardiomegaly; Fibrosis; Gene Expression Regulation; Heterocyclic Compounds, 4 or More Rings; Ion Channels; Mice; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Proteins; Myocardial Contraction; Myocardium; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes; Superoxides; Transcription Factors; Uncoupling Protein 2 | 2014 |
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins | 2015 |
Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway.
Topics: Animals; Cardiomegaly; Cells, Cultured; Collagen; Fibrosis; Heart; Male; Mice; Myocardium; Myocytes, Cardiac; Myofibroblasts; Resveratrol; Sirtuin 3; Smad3 Protein; Stilbenes; Transforming Growth Factor beta | 2015 |
Resveratrol Attenuated Low Ambient Temperature-Induced Myocardial Hypertrophy via Inhibiting Cardiomyocyte Apoptosis.
Topics: Animals; Apoptosis; Cardiomegaly; Caspase 3; Cold Temperature; Fibrosis; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Resveratrol; Signal Transduction; Stilbenes; Up-Regulation | 2015 |
Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3.
Topics: Acetylation; Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Fructosamine; Heart; Histones; Male; NADPH Oxidases; Nitric Oxide; Oxidative Stress; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase; Transcription Factor RelA | 2015 |
Resveratrol Ameliorates Cardiac Hypertrophy by Down-regulation of miR-155 Through Activation of Breast Cancer Type 1 Susceptibility Protein.
Topics: Animals; Blotting, Western; BRCA1 Protein; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Enzyme Inhibitors; Gene Expression Regulation; Immunohistochemistry; Male; Mice; MicroRNAs; Myocytes, Cardiac; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA; Stilbenes | 2016 |
The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Disease Models, Animal; Heart; Male; Myocardium; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Transcription, Genetic | 2017 |
Inhibition of Cardiomyocytes Hypertrophy by Resveratrol Is Associated with Amelioration of Endoplasmic Reticulum Stress.
Topics: Animals; Animals, Newborn; Antioxidants; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Cell Size; Cells, Cultured; Endoplasmic Reticulum Stress; Gene Expression; Heat-Shock Proteins; Isoproterenol; Microscopy, Electron, Transmission; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2016 |
Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.
Topics: Animals; Blood Pressure; Cardiomegaly; Cell Survival; Disease Models, Animal; Heart Failure; Heart Function Tests; MAP Kinase Signaling System; Myocytes, Cardiac; Polyphenols; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2017 |
Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Mice; Multienzyme Complexes; Myocytes, Cardiac; Peptide Elongation Factor 2; Phenylephrine; Protein Biosynthesis; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Stilbenes; Transcription, Genetic | 2008 |
Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Topics: Aldehydes; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Cardiomegaly; Cells, Cultured; Hypertension; Hypertrophy, Left Ventricular; Lipid Peroxidation; Myocytes, Cardiac; Oxidative Stress; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2009 |
Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure.
Topics: Aging; Animals; Antioxidants; Blood Pressure; Cardiomegaly; Echocardiography; Heart Function Tests; Hypertension; Lipid Peroxidation; Male; Myocardial Contraction; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Resveratrol; Stilbenes | 2010 |
Resveratrol alleviates some cardiac dysfunction indexes in an SHR model of essential hypertension.
Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Contraction; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2010 |
Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats.
Topics: Animals; Antioxidants; Cardiomegaly; Disease Models, Animal; Heart; Lipid Peroxidation; Male; Myocardium; Oxidative Stress; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Ventricular Pressure | 2010 |
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes.
Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Genes; Heart; Humans; Hypertension; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Resveratrol; Stilbenes | 2010 |
Roles and controls of mTOR in the heart. Focus on "mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy".
Topics: Animals; Cardiomegaly; Heart; Myocarditis; Myocytes, Cardiac; Rats; Resveratrol; Stilbenes; TOR Serine-Threonine Kinases; Triiodothyronine | 2010 |
Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Energy Metabolism; Fatty Acids; Gene Expression; Lipid Metabolism; Mice; Mice, Mutant Strains; Myocarditis; Myocytes, Cardiac; NF-kappa B; Oxidation-Reduction; PPAR alpha; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Stilbenes | 2011 |
Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Cardiomyopathies; Down-Regulation; Dystrophin; E1A-Associated p300 Protein; Echocardiography; Male; Mice; Mice, Inbred C57BL; Models, Biological; Phenylephrine; Proteasome Endopeptidase Complex; Resveratrol; Sirtuin 1; Stilbenes; Ubiquitin | 2013 |
Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Topics: Angiotensin II; Animals; Antioxidants; Aorta; Blood Pressure; Blotting, Western; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Enzyme Activation; Free Radicals; Glutathione Peroxidase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart; Heart Ventricles; Hydrogen Peroxide; L-Lactate Dehydrogenase; Leucine; Lipid Peroxidation; Malondialdehyde; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Chemical; Myocytes, Cardiac; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Stilbenes; Superoxide Dismutase; Time Factors; Transcription Factor AP-1 | 2005 |
Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension, Renal; Male; Myocardium; Nephrectomy; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
[Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Endothelin-1; Hypertension; Male; Myocardium; Nephrectomy; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2005 |
Resveratrol ameliorates experimental autoimmune myocarditis.
Topics: Animals; Autoimmune Diseases; Cardiomegaly; Cardiomyopathy, Dilated; Cardiotonic Agents; Chemotaxis, Leukocyte; Disease Models, Animal; Electrocardiography; Female; Inflammation; Leukocytes, Mononuclear; Myocarditis; Myosins; Rats; Rats, Inbred Lew; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes | 2007 |
Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the alpha-myosin heavy chain expression.
Topics: Animals; Antioxidants; Antithyroid Agents; Blotting, Western; Cardiomegaly; Cell Size; Cells, Cultured; Densitometry; Diet; Enzyme Activation; Fibrosis; Fructose; Male; Mice; Mice, Transgenic; Myocardium; Myosin Heavy Chains; NAD; Nutritional Physiological Phenomena; Propylthiouracil; Resveratrol; RNA; Sirtuin 1; Sirtuins; Stilbenes; Transfection | 2008 |